Why Portola Pharmaceuticals Is Rocketing 10.9% Higher Today
After the company reported second-quarter revenue that was better than industry watchers were expecting, shares in Portola Pharmaceuticals (NASDAQ: PTLA) shot up 10.9% as of 3 p.m. EDT on Thursday.
Portola Pharmaceuticals has launched two highly anticipated drugs since 2017. But one, Bevyxxa, was a dud; the second drug, Andexxa, got off to a slow start because of changes to its manufacturing process.
IMAGE SOURCE: GETTY IMAGES.
Quelle Fool.com
